KURN — Kuros Biosciences AG Share News
0.000.00%
Last trade - 00:00- CH₣828.53m
- CH₣831.76m
- $146.06m
Brief: Kuros Biosciences Convenes Extraordinary Shareholders General Meeting
Brief: Kuros Biosciences Obtains U.S. Patent Covering A Method For Producing Osteoinductive Materials
Swiss stocks - Factors to watch on Sept. 28
Brief: Kuros Biosciences Reports First Patient Treated In Randomized Controlled Trial Of MagnetOs In Spinal Fusion
Swiss stocks - Factors to watch on Sept. 26
Brief: Kuros Biosciences H1 Net Loss At CHF 5.2 Mln
Brief: Kuros Biosciences Appoints Pascal Longlade As Chief Medical Officer
Brief: Kuros Biosciences Reports First US & UK Sales Of Magnetos Commercial Roll-Out In US And Europe On Track
Brief: Kuros Biosciences To Present Promising Clinical Case Studies With Magnetos At Leading Spine Surgery Conference
Brief: Kuros Biosciences Announces Start Of Of Randomized Controlled Trial Of Magnetos In Spinal Fusion
Swiss stocks - Factors to watch on June 1
Brief: Kuros Biosciences To Propose Appointment Of New Board Members At AGM
Brief: Kuros Biosciences To Propose Appointment Of New Board Members At AGM
Swiss stocks - Factors to watch on May 30
Brief: Kuros Biosciences Announces Start Of Investigator-Led Study Of Magnetos Granules For Maxillary Sinus Floor Elevation
Brief: Kuros Biosciences Receives European Clearance For Magnetos Putty
Brief: Kuros Biosciences FY Loss At EUR 16.5 Mln
Brief: Kuros Biosciences: Expands License Agreement With Checkmate
Brief: Kuros Biosciences Appoints Michael Grau As CFO Effective Feb 1, 2018